Richard O. Day
- Pharmacology top 0.02%
- Molecular Biology top 1%
- Surgery top 0.5%
- Pharmacology top 0.02%
- Rheumatology top 0.2%
- Co-authors
- M. FullerVictor A. SchmidtGarry G. GrahamAndrew J. McLachlanKenneth M. WilliamsPeter BrooksJohanna WestbrookDeborah R. Shapiro
- Topics
- Inflammatory mediators and NSAID effects (67 papers)Gout, Hyperuricemia, Uric Acid (60 papers)Pharmaceutical Practices and Patient Outcomes (54 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Richard O. Day
592 papers receiving 23.8k citations
Hit Papers
Peers
Comparison fields: 5 of 219
- Pharmacology 7.3k
- Molecular Biology 5.7k
- Surgery 3.4k
- Pharmacology 2.8k
- Rheumatology 2.6k
Countries citing papers authored by Richard O. Day
This map shows the geographic impact of Richard O. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard O. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard O. Day more than expected).
Fields of papers citing papers by Richard O. Day
This network shows the impact of papers produced by Richard O. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard O. Day. The network helps show where Richard O. Day may publish in the future.
Co-authorship network of co-authors of Richard O. Day
This figure shows the co-authorship network connecting the top 25 collaborators of Richard O. Day. A scholar is included among the top collaborators of Richard O. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard O. Day. Richard O. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 14 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 16 | |
| 9 | 29 | |
| 10 | 0 | |
| 11 | 4 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | 16 | |
| 15 | 5 | |
| 16 | 0 | |
| 17 | 9 | |
| 18 | 7 | |
| 19 | 11 | |
| 20 | 108 |
About Richard O. Day
Richard O. Day is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Health Information Management, having authored 615 papers that have together received 25.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (67 papers), Gout, Hyperuricemia, Uric Acid (60 papers) and Pharmaceutical Practices and Patient Outcomes (54 papers). The work is most often cited by research in Pharmacology (7.3k citations), Pharmacology (2.8k citations) and Geriatrics and Gerontology (986 citations). Richard O. Day has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include M. Fuller, Victor A. Schmidt, Garry G. Graham, Andrew J. McLachlan, Kenneth M. Williams, Peter Brooks, Kenneth M. Williams, Johanna Westbrook, Deborah R. Shapiro and Tore K Kvien. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.